| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 19 |
| 1 | ACETAMINOPHEN 500MG | 17 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 17 |
| 3 | PAIN RELIEVER | 17 |
| 4 | OXALIPLATIN | 14 |
| 5 | PREDNISONE | 14 |
| 6 | SODIUM CHLORIDE | 14 |
| 7 | CYCLOPHOSPHAMIDE | 13 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 29 |
| 1 | Platinum-based Drug [EPC] | 27 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 22 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 16 |
| 5 | Alkylating Drug [EPC] | 15 |
| 6 | Osmotic Laxative [EPC] | 13 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 8 | Thalidomide Analog [EPC] | 12 |
| 9 | Kinase Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 4 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 5 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 22 | 0.0002 |
| 7 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 8 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 9 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |